Lyell Immunopharma upgraded to Buy as ronde-cel CAR-T advances in r/r LBCL, backed by fresh funding and key trial catalysts. Learn more about LYEL stock here.
CryptoAlerta — análise de criptomoedas e mercado em tempo real